10 results
8-K
EX-99.1
IMVT
Immunovant Inc
8 Dec 22
Regulation FD Disclosure
7:06am
Demyelinating Polyneuropathy; EAN/PNS = European Academy of Neurology/Peripheral Nerve Society; Ig = immunoglobulin (IVIG and SCIG) therapy; IMP
8-K
EX-99.1
IMVT
Immunovant Inc
7 Sep 22
Regulation FD Disclosure
6:39am
of Neurology/Peripheral Nerve Society; Ig = immunoglobulin (IVIG and SCIG) therapy; IMP = investigational medicinal product; LTE = Long-term Extension
DEFA14A
EX-99.1
IMVT
Immunovant Inc
29 Oct 19
Additional proxy soliciting materials
1:50pm
be the optimal outcome for society and for shareholders. I would think this is more likely to be the case now than at any time in the last couple of decades
8-K
EX-99.1
IMVT
Immunovant Inc
29 Oct 19
This report is prepared solely for the use of John Strumbos
1:48pm
be the optimal outcome for society and for shareholders. I would think this is more likely to be the case now than at any time in the last couple of decades
424B4
woa2t u0wt8jst
10 May 19
Prospectus supplement with pricing info
5:18pm
S-1
e9q9d7 9d
15 Apr 19
IPO registration
9:56pm
DRS/A
0ccy23drtxg
26 Feb 19
Draft registration statement (amended)
12:00am
DRS
ersrdg3 lswmy0ql4hp9
23 Jan 19
Draft registration statement
12:00am
- Prev
- 1
- Next